FigureĀ 4.
Kaplan-Meier survival curves of the HSCT patients. (A) OS by the HLH status at HSCT. (B) OS by the HLH status and timing of HSCT. (C) OS by the chimerism. (D) OS by the EBV-infected cell lineages.

Kaplan-Meier survival curves of the HSCT patients. (A) OS by the HLH status at HSCT. (B) OS by the HLH status and timing of HSCT. (C) OS by the chimerism. (D) OS by the EBV-infected cell lineages.

or Create an Account

Close Modal
Close Modal